Free Trial

Insigneo Advisory Services LLC Lowers Stake in Aflac Incorporated (NYSE:AFL)

Aflac logo with Finance background

Insigneo Advisory Services LLC trimmed its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 43.2% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 4,134 shares of the financial services provider's stock after selling 3,142 shares during the period. Insigneo Advisory Services LLC's holdings in Aflac were worth $460,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Private Trust Co. NA grew its holdings in Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider's stock valued at $791,000 after buying an additional 99 shares in the last quarter. Optas LLC boosted its stake in Aflac by 3.5% during the first quarter. Optas LLC now owns 2,949 shares of the financial services provider's stock worth $328,000 after buying an additional 101 shares during the period. TKG Advisors LLC boosted its stake in shares of Aflac by 0.5% during the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider's stock worth $2,230,000 after purchasing an additional 103 shares during the period. Family Legacy Inc. boosted its stake in shares of Aflac by 4.3% during the 4th quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock worth $270,000 after purchasing an additional 107 shares during the period. Finally, Ashton Thomas Private Wealth LLC boosted its position in shares of Aflac by 1.9% during the fourth quarter. Ashton Thomas Private Wealth LLC now owns 5,927 shares of the financial services provider's stock valued at $613,000 after buying an additional 110 shares during the period. Hedge funds and other institutional investors own 67.44% of the company's stock.

Wall Street Analyst Weigh In

AFL has been the subject of several research reports. Barclays boosted their price objective on shares of Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a research report on Thursday, May 1st. Raymond James Financial decreased their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Wall Street Zen cut shares of Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Piper Sandler raised their price objective on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Finally, Keefe, Bruyette & Woods raised their target price on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a report on Wednesday, May 7th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Aflac has an average rating of "Hold" and a consensus target price of $104.93.

View Our Latest Analysis on Aflac

Insider Buying and Selling

In other news, Director Masatoshi Koide sold 37,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the transaction, the director now owns 70,992 shares of the company's stock, valued at approximately $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Arthur Reginald Collins sold 2,750 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the transaction, the director now directly owns 6,728 shares of the company's stock, valued at $711,149.60. This represents a 29.01% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 40,750 shares of company stock worth $4,304,295. Company insiders own 0.90% of the company's stock.

Aflac Price Performance

NYSE:AFL opened at $102.56 on Thursday. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $88.00 and a 12 month high of $115.50. The firm has a market cap of $55.45 billion, a P/E ratio of 16.02, a price-to-earnings-growth ratio of 3.16 and a beta of 0.82. The stock has a 50 day moving average of $105.02 and a two-hundred day moving average of $105.35.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.67 by ($0.01). The business had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm's revenue was down 37.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.66 EPS. On average, analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a $0.58 dividend. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 annualized dividend and a dividend yield of 2.26%. Aflac's dividend payout ratio (DPR) is 36.25%.

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

See Also

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aflac Right Now?

Before you consider Aflac, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.

While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines